What Are the Most Important Drug Interactions with Hydrochlorothiazide?

Hydrochlorothiazide (HCTZ) has two documented contraindicated combinations and several major interactions that require careful monitoring or avoidance. The most serious are with lithium (a mood-stabilizing medication used for bipolar disorder) and with dofetilide (a heart-rhythm medication). Additionally, several other drug classes can reduce how well hydrochlorothiazide works, cause dangerous electrolyte loss, or create serious blood-pressure and kidney complications when combined with it. This guide explains what the FDA drug labeling and other authoritative sources say about these interactions and what you should discuss with your pharmacist or doctor.

What Is Hydrochlorothiazide?

Hydrochlorothiazide is a thiazide diuretic—a water pill that helps your kidneys remove sodium and water from your body. It is commonly prescribed to lower blood pressure and is often combined with other blood-pressure medications in fixed-dose tablets. It works by widening blood vessels and reducing the amount of fluid in circulation, which decreases pressure on artery walls.

Because diuretics remove fluid and electrolytes (minerals like potassium and sodium that cells need to function), hydrochlorothiazide can lower your potassium levels and affect how your kidneys filter blood. This basic pharmacology is important to understand why certain drug combinations are dangerous: when another drug also depletes potassium or affects kidney function, the risks compound.

The Two Contraindicated Combinations: Lithium and Dofetilide

A "contraindication" means a drug combination should not be used together under any circumstances, or only in exceptional situations with very close medical supervision.

Hydrochlorothiazide and Lithium

This is the most well-established contraindicated pair in the FDA labeling. Hydrochlorothiazide should not be given with lithium because the diuretic reduces how quickly your kidneys clear lithium from your body. Lithium is eliminated almost entirely through the kidneys, and when kidney clearance slows, lithium can build up to toxic levels in your blood.

Lithium toxicity is a medical emergency. Early signs include nausea, vomiting, diarrhea, tremor, confusion, and irregular heartbeat. Severe toxicity can cause seizures, kidney damage, or death. Because lithium has a narrow therapeutic window—meaning the difference between an effective dose and a toxic dose is small—even modest reductions in kidney clearance can be dangerous.

If you take lithium and your doctor prescribes a blood-pressure medication, you need a different option. If you take hydrochlorothiazide as part of a combination tablet and also take lithium, contact your pharmacist or doctor immediately; do not stop the medication on your own, but get guidance right away on switching one of them.

Hydrochlorothiazide and Dofetilide

According to the FDA drug label for dofetilide (a medication that corrects irregular heart rhythms), hydrochlorothiazide alone or in combination with triamterene is contraindicated. The source record does not specify a mechanism, but the practical concern is that diuretics can lower potassium and magnesium, both of which affect how dofetilide is handled by the heart. Dofetilide requires very careful dosing and monitoring because it can itself cause life-threatening arrhythmias if blood levels are too high or if electrolytes are abnormal.

If you take dofetilide and a blood-pressure medication is needed, your cardiologist and primary care doctor must work together to choose an alternative to hydrochlorothiazide.

Major Interactions: RAS Inhibitors and Aliskiren Combinations

Several FDA drug labels discuss major interactions between hydrochlorothiazide and medications that affect the renin-angiotensin system (RAS)—a set of hormones that control blood pressure and kidney function. These include:

• Lisinopril and hydrochlorothiazide tablets
• Enalapril maleate and hydrochlorothiazide
• Telmisartan and hydrochlorothiazide tablets
• Irbesartan and hydrochlorothiazide tablets

It is important to note that some of these are already combinations—the medications are formulated together in a single tablet. In those cases, the interaction refers to avoiding additional RAS-affecting drugs, particularly aliskiren (a direct renin inhibitor).

The documented guidance from FDA labels is:

• Do not use aliskiren together with any of these combination tablets in patients with diabetes.
• Avoid aliskiren if you are on one of these combinations and have reduced kidney function (glomerular filtration rate, or GFR, less than 60 mL/min).
• Closely monitor blood pressure, kidney function, and electrolyte levels.

Why is this dangerous? When multiple RAS-blocking drugs are used together, blood pressure can drop too far, kidney function can deteriorate rapidly, and potassium can rise to dangerous levels (a condition called hyperkalemia). Patients with diabetes are at particularly high risk of kidney damage from this combination.

Major Interactions: Electrolyte Depletion

Hydrochlorothiazide causes potassium loss. When you take it with another medication that also causes potassium loss, the effect is additive—you lose more potassium than you would on either drug alone. Two drug classes documented in the source records carry this risk:

Corticosteroids

Corticosteroids (such as prednisone, methylprednisolone, or dexamethasone) are used to reduce inflammation in conditions like asthma, autoimmune diseases, and allergic reactions. According to the source data, combined use of corticosteroids and hydrochlorothiazide can cause intensified electrolyte depletion, particularly hypokalemia (low potassium).

Low potassium can cause muscle weakness, cramps, irregular heartbeat, and fatigue. If you take both a corticosteroid and hydrochlorothiazide, your doctor may recommend potassium monitoring or a potassium supplement, and may ask you to eat potassium-rich foods like bananas, spinach, and sweet potatoes.

Repository Corticotropin

Repository corticotropin (ACTH, adrenocorticotropic hormone) is a hormone medication that stimulates the body to produce its own corticosteroids. Like corticosteroids themselves, it carries a documented risk of intensified electrolyte depletion when used with hydrochlorothiazide, particularly low potassium.

Major Interactions: Reduced Absorption of Hydrochlorothiazide

Two bile-acid-binding resins—medications used to lower cholesterol—can significantly reduce how much hydrochlorothiazide your body absorbs. If absorption is reduced, the diuretic may not work as well to lower your blood pressure.

Cholestyramine Light

According to the source data, cholestyramine light can reduce the absorption of hydrochlorothiazide by up to 85% in a single dose. The mechanism is that cholestyramine is an anionic exchange resin—it binds certain drugs in the gastrointestinal tract, preventing them from crossing into the bloodstream. If you take both medications, the usual recommendation is to separate them by several hours (often at least 30 minutes to 1 hour, but ask your pharmacist for the exact timing). Taking hydrochlorothiazide several hours before cholestyramine may allow better absorption.

Colestipol Hydrochloride

Colestipol hydrochloride also significantly decreases the absorption of hydrochlorothiazide through the same binding mechanism. Like cholestyramine, colestipol should be separated from hydrochlorothiazide in time to minimize the interaction.

Key Documented Interactions at a Glance

• Contraindicated: Lithium—risk of lithium toxicity due to reduced kidney clearance
• Contraindicated: Dofetilide—risk of serious arrhythmia due to electrolyte and clearance changes
• Major—RAS inhibitors: Lisinopril, enalapril, telmisartan, irbesartan combinations; avoid aliskiren, especially in diabetes or kidney disease
• Major—Electrolyte depletion: Corticosteroids and repository corticotropin; monitor potassium
• Major—Reduced absorption: Cholestyramine light and colestipol hydrochloride; separate by time

Hypothetical Scenarios: How These Interactions Matter in Practice

Scenario 1: Lithium and blood pressure control. Imagine you manage bipolar disorder with lithium, and your doctor recommends starting hydrochlorothiazide for high blood pressure. According to the FDA source record, this combination is contraindicated. Your doctor would likely choose a different antihypertensive—perhaps a beta-blocker, calcium-channel blocker, or a different type of diuretic (though all diuretics warrant caution with lithium). This is why it is critical to tell every doctor you see that you take lithium.

Scenario 2: Cholesterol and blood pressure together. Suppose you take hydrochlorothiazide for high blood pressure and cholestyramine to lower your cholesterol. The source data show that cholestyramine can reduce hydrochlorothiazide absorption by up to 85% in a single dose. If you take them at the same time, your blood pressure medication may not work well. The solution is to take them at different times of day—for example, hydrochlorothiazide in the morning and cholestyramine at lunch, several hours apart. Your pharmacist can suggest the best timing for your specific medications.

Questions to Ask Your Pharmacist or Physician

When you are prescribed hydrochlorothiazide or when your medications change, ask your healthcare provider:

1. Do I take any medications that cannot be combined with hydrochlorothiazide? Make sure to mention lithium, dofetilide, corticosteroids, cholestyramine, colestipol, and any other blood-pressure or heart medications.
2. Should my potassium levels be checked? Ask whether you need blood tests to monitor potassium, especially if you take corticosteroids or repository corticotropin alongside hydrochlorothiazide.
3. How should I take my medications if I am on cholestyramine or colestipol? Ask about the timing—how many hours apart should hydrochlorothiazide and these cholesterol medications be separated?
4. If I take a combination tablet with hydrochlorothiazide, are there other blood-pressure drugs I should avoid? This is especially important if you are on lisinopril/HCTZ, enalapril/HCTZ, telmisartan/HCTZ, or irbesartan/HCTZ; ask about aliskiren in particular, and mention any history of diabetes or kidney disease.
5. What are the early signs of problems I should watch for? Ask about symptoms of low potassium (weakness, cramps, irregular heartbeat) and signs that blood pressure is dropping too far (dizziness, fainting).
6. Should I eat more potassium-rich foods or take a supplement? Your doctor may recommend dietary changes or a potassium supplement to offset the loss caused by hydrochlorothiazide.

Key Takeaways

• Two drug combinations are contraindicated (should not be used together): hydrochlorothiazide with lithium and hydrochlorothiazide with dofetilide. If you take either of these medications, inform your doctor before starting hydrochlorothiazide.
• RAS inhibitor combinations (lisinopril/HCTZ, enalapril/HCTZ, telmisartan/HCTZ, irbesartan/HCTZ) require caution with aliskiren—especially in patients with diabetes or kidney disease—and close monitoring of blood pressure, kidney function, and electrolytes.
• Corticosteroids and repository corticotropin cause additive potassium loss when combined with hydrochlorothiazide; ask your doctor about potassium monitoring and supplementation.
• Cholestyramine and colestipol significantly reduce hydrochlorothiazide absorption; separate these medications by time to maintain the diuretic's effectiveness.
• Always disclose all your medications—including over-the-counter drugs, supplements, and herbal products—to your pharmacist and doctor when starting hydrochlorothiazide or any other new medication.

Sources

The information in this guide comes from FDA-approved drug labels and the National Library of Medicine RxNorm database:

• DailyMed: FDA Drug Labels and Labeling — source for dofetilide, lisinopril and hydrochlorothiazide, enalapril maleate and hydrochlorothiazide, telmisartan and hydrochlorothiazide, and irbesartan and hydrochlorothiazide labeling
• NLM RxNorm: Normalized Naming System for Clinical Drugs — curated drug interaction reference for hydrochlorothiazide, lithium, corticosteroids, repository corticotropin, cholestyramine light, and colestipol hydrochloride
• Open FDA: Drug, Device, and Food Adverse Event Data — FDA's public interface to drug labeling and safety information
• PubMed: National Center for Biotechnology Information — for peer-reviewed medical literature on drug interactions

Important Disclaimer and Next Steps

This guide explains what FDA drug labels and authoritative pharmaceutical databases say about hydrochlorothiazide interactions. It is not a substitute for professional medical advice, diagnosis, or treatment. Drug interactions can vary based on dose, individual kidney and liver function, age, and other health conditions. Never start, stop, skip, or substitute a medication without guidance from your pharmacist or physician.

If you are taking hydrochlorothiazide and believe you may be experiencing side effects or signs of an interaction—such as muscle weakness, irregular heartbeat, severe dizziness, confusion, or nausea—contact your doctor or pharmacist right away, or call emergency services if symptoms are severe.

To check for interactions between all of your medications, visit checkdruginteractions.com and search your complete medication list. Then confirm your medication regimen with a licensed pharmacist or physician who knows your full medical history and current health status.